This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Free Online Activities

What Have We Learned About Bipolar Disorder From STEP-BD and Other Practical Trials?

Andrew A. Nierenberg, MD

Published: August 15, 2009

This CME activity is expired. For more CME activities, visit CMEInstitute.com.
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

Article Abstract

Certain developments are informing the treatment of patients with bipolar disorder. Results from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) study and other pragmatic clinical trials are providing practical information on relapse/recurrence, comorbidities, and pharmacologic and psychosocial treatment. Also, the Bipolar Trials Network (BTN) has been established to provide an infrastructure for National Institutes of Health (NIH) and trials with high public health significance. More research is needed to explore fundamental questions about bipolar disorder and its treatment.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 70

Quick Links: Bipolar Disorder

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...

Read More...